Thank you for Registering for the Final Live Webinar in our 4-Part Series
HVAD Post ECMO: Recovery to Discharge
The LIVE webcast will start to stream to this page beginning at 6 PM CT. If the live webcast player is not showing above, please refresh your page and click the play button to join
In this final webinar of the series, Drs. Rich and Klein will explore the current outcomes data and discuss current best practices in managing patients from ECMO to a durable VAD to discharge, and beyond. They will cover surgical, medical and patient management techniques for the unique needs of this population.
Jonathan Rich, MD
Associate Professor of Medicine
Medical Director, MCS
Liviu Klein, MD
Associate Professor of Medicine
Director, MCS and Cardiology Clinical Research
University of California
San Francisco, CA
Medtronic HVAD™ System Brief Statement
Indications for Use
The Medtronic HVAD System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a Bridge to Cardiac Transplantation (BTT), myocardial recovery, or as Destination Therapy (DT) in patients for whom subsequent transplantation is not planned.
The HVAD System is contraindicated in patients who cannot tolerate anticoagulation therapy.
Proper usage and maintenance of the HVAD System is critical for the functioning of the device. Serious and life-threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta - use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post CPR.
Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and device-related thromboembolic events, bleeding, right ventricular failure, infection, hemolysis and sepsis.
Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions and potential adverse events prior to using this device.
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.
Virtual Meeting Disclaimer
The information presented in these webinars is the opinion and experience of the physician or clinician and represents their experience. It is not intended to constitute medical advice or in any way replace the independent medical judgment of a trained and licensed physician with respect to any patient needs or circumstances.